{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:34:31Z","timestamp":1778276071680,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2928,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.ki.5002564","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T14:49:11Z","timestamp":1192027751000},"page":"1483-1492","source":"Crossref","is-referenced-by-count":58,"title":["Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia"],"prefix":"10.1016","volume":"72","author":[{"given":"S.","family":"Reungjui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Roncal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.P.","family":"Croker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Byer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Sitprija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5002564_bb0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002564_bb0015","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002564_bb0020","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium-channel blocker vs. diuretic","volume":"288","author":"The ALLHAT Study Group","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/sj.ki.5002564_bb0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.HYP.17.4.579","article-title":"Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY study","volume":"17","author":"Wikstrand","year":"1991","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002564_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term low-dose diuretic-based antihypertensive therapy on glucose, lipid, uric acid and potassium levels in older men and women with isolated systolic hypertension. The systolic hypertension in the elderly program","volume":"158","author":"Savage","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5002564_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomized to double-blind treatment with a long acting calcium-channel blocker or diuretic in the international nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002564_bb0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2004.12.007","article-title":"Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis","volume":"18","author":"Hawkins","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/107424849600100109","article-title":"Hydrochlorothiazide increases efferent glomerular arteriolar resistance in spontaneously hypertensive rats","volume":"1","author":"Komatsu","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1038\/sj.ki.5002564_bb0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00004872-199607000-00004","article-title":"Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats","volume":"14","author":"Ono","year":"1996","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/j.1552-4604.1995.tb05009.x","article-title":"First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension","volume":"35","author":"Frishman","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1038\/sj.ki.5002564_bb0060","first-page":"49","article-title":"The heart in hypertension and arrhythmias","volume":"15","author":"Widimsky","year":"1990","journal-title":"Herz"},{"key":"10.1038\/sj.ki.5002564_bb0065","first-page":"331","article-title":"The incidence of diuretic-induced hypokalemia in two distinct clinic settings","volume":"2","author":"Bloomfield","year":"1986","journal-title":"J Clin Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0070","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/clinchem\/30.5.754","article-title":"Relationship of potassium and magnesium concentrations in serum to cardiac arrhythmias","volume":"30","author":"Boyd","year":"1984","journal-title":"Clin Chem"},{"key":"10.1038\/sj.ki.5002564_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0954-6820.1981.tb02640.x","article-title":"Thiazide diuretics, hypokalemia and cardiac arrhythmias","volume":"647","author":"Hollifield","year":"1981","journal-title":"Acta Med Scand Suppl"},{"key":"10.1038\/sj.ki.5002564_bb0080","first-page":"554","article-title":"Low-dose diuretic therapy for hypertension","volume":"8","author":"Moser","year":"1986","journal-title":"Clin Ther"},{"key":"10.1038\/sj.ki.5002564_bb0085","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1172\/JCI112973","article-title":"Hypokalemic nephropathy in the rat: role of ammonia in chronic tubular injury","volume":"79","author":"Tolins","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002564_bb0090","doi-asserted-by":"crossref","first-page":"F620","DOI":"10.1152\/ajprenal.2001.281.4.F620","article-title":"Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity","volume":"281","author":"Suga","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002564_bb0095","first-page":"1955","article-title":"Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet","volume":"274","author":"Yang","year":"1998","journal-title":"Am J Physiol"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5002564_bb0100","first-page":"1126","article-title":"Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy","volume":"19","author":"Plavinik","year":"1992","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002564_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11906-004-0084-7","article-title":"Antihypertensive and lipid-lowering heart attack trial study; trinity hypertension research institute. Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study","volume":"6","author":"Punzi","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/sj.ki.5002564_bb0110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","article-title":"Adverse prognostic significance of new diabetes in treated hypertensive subjects","volume":"43","author":"Verdecchia","year":"2004","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002564_bb0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"Serum uric acid, diuretic treatment and risk of cardiovascular events in the systolic hypertension in the elderly program","volume":"18","author":"Franse","year":"2000","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0120","series-title":"Comprehensive Clinical Nephrology","first-page":"725","article-title":"Atheromatous and thromboembolic renovascular disease","volume":"Vol. 3","author":"Lewis","year":"2007"},{"key":"10.1038\/sj.ki.5002564_bb0125","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00004872-200312000-00027","article-title":"Distribution of nitric oxide synthases and nitrotyrosine in the kidney of spontaneously hypertensive rats","volume":"21","author":"Fernandez","year":"2003","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0130","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1152\/ajpregu.2002.282.1.R31","article-title":"Changes in NOS activity and protein expression during acute and prolonged ANG II administration","volume":"282","author":"Moreno","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1038\/sj.ki.5002564_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ki.1996.328","article-title":"Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes\/macrophages","volume":"50","author":"Kashem","year":"1996","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0140","first-page":"755","article-title":"Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats","volume":"71","author":"Buttery","year":"1994","journal-title":"Lab Invest"},{"key":"10.1038\/sj.ki.5002564_bb0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ki.1994.318","article-title":"Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney","volume":"46","author":"Mohaupt","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI115826","article-title":"Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors","volume":"90","author":"Takahashi","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5002564_bb0155","doi-asserted-by":"crossref","first-page":"F279","DOI":"10.1152\/ajprenal.00073.2007","article-title":"Vasodilation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice","volume":"293","author":"Oppermann","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002564_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005344-199109000-00007","article-title":"Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension","volume":"18","author":"Koenig","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/sj.ki.5002564_bb0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0954-6820.1980.tb09718.x","article-title":"Body fluid volumes and the response of renin and aldosterone to short- and long-term thiazide therapy of essential hypertension","volume":"207","author":"van Brummelen","year":"1980","journal-title":"Acta Med Scand"},{"key":"10.1038\/sj.ki.5002564_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1254\/fpj.124.101","article-title":"Aldosterone and renal injury","volume":"124","author":"Nishiyama","year":"2004","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1038\/sj.ki.5002564_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1254\/jphs.FMJ05003X3","article-title":"Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade","volume":"100","author":"Nishiyama","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"10.1038\/sj.ki.5002564_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/08860220600779033","article-title":"Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well","volume":"28","author":"Gullulu","year":"2006","journal-title":"Ren Fail"},{"key":"10.1038\/sj.ki.5002564_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.ki.5000438","article-title":"Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats","volume":"70","author":"Han","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0195","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","article-title":"Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker","volume":"47","author":"Nagase","year":"2006","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5002564_bb0200","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0205","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1681\/ASN.2004090804","article-title":"Regression of existing glomerulosclerosis by inhibition of aldosterone","volume":"16","author":"Aldigier","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002564_bb0210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/labinvest.3700052","article-title":"Comparison of renal morphology in the streptozotocin and the SHR\/N-cp models of diabetes","volume":"84","author":"Gross","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/sj.ki.5002564_bb0215","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1469-7580.2005.00492.x","article-title":"A stereological study of the renal glomerular vasculature in the db\/db mouse model of diabetic nephropathy","volume":"207","author":"Guo","year":"2005","journal-title":"J Anat"},{"key":"10.1038\/sj.ki.5002564_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semnephrol.2004.10.001","article-title":"Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease","volume":"25","author":"Kang","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5002564_bb0225","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0272-6386(03)00193-8","article-title":"High urine volume and low urine osmolality are risk factors for faster progression of renal disease","volume":"41","author":"Hebert","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002564_bb0230","first-page":"581","article-title":"Diuretic resistance: physiology and therapeutics","volume":"19","author":"Ellison","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5002564_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0021-9150(81)90075-7","article-title":"Furosemide-induced hyperuricemia, hyperglycemia, hypertension and arterial lesions in nonarteriosclerotic and arteriosclerotic rats","volume":"39","author":"Wexler","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1038\/sj.ki.5002564_bb0240","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1523-1755.2001.0590041211.x","article-title":"Renoprotection: one or many therapies?","volume":"59","author":"Hebert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002564_bb0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0895-7061(97)00309-9","article-title":"Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR)","volume":"11","author":"Webb","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1038\/sj.ki.5002564_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cvr\/24.2.137","article-title":"Effects of antihypertensive drugs on heart and resistance vessels","volume":"24","author":"Kobayashi","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1038\/sj.ki.5002564_bb0255","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","article-title":"A causal role for uric acid in fructose-induced metabolic syndrome","volume":"290","author":"Nakagawa","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5002564_bb0260","first-page":"CR480","article-title":"Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique","volume":"10","author":"Straczkowski","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1038\/sj.ki.5002564_bb0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/cs0740241","article-title":"A simple and rapid method for the determination of the concentrations of magnesium, sodium, potassium and sodium, potassium pumps in human skeletal muscle","volume":"74","author":"Dorup","year":"1988","journal-title":"Clin Sci"},{"key":"10.1038\/sj.ki.5002564_bb0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/10731199509117963","article-title":"Protective effect of selenium on hemoglobin mediated lipid peroxidation in vivo","volume":"23","author":"Simoni","year":"1995","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"10.1038\/sj.ki.5002564_bb0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1211\/0022357055614","article-title":"Scavenging of nitric oxide by an antagonist of adenosine receptors","volume":"57","author":"Sousa","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1038\/sj.ki.5002564_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2143\/AC.55.4.2005744","article-title":"Endothelial dysfunction in hypertension","volume":"55","author":"Puddu","year":"2000","journal-title":"Acta Cardiol"},{"key":"10.1038\/sj.ki.5002564_bb0285","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1681\/ASN.2005070759","article-title":"Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy","volume":"17","author":"Nakagawa","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T12:31:43Z","timestamp":1708259503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815525945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0085253815525945"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002564","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}